Max Nisen
Columnist
Nisen is a Bloomberg Gadfly columnist covering biotech, pharma and health care. He previously wrote about management and corporate strategy for Quartz and Business Insider.
More From Employee Benefit News
Helping employees select the right healthcare during open enrollment
Employers should educate staff on the nuances of every coverage option, advises Benefitbay CEO, ranging from coinsurance to coverage tiers, networks, “incumbent bias,” and more.
Forging stronger broker-TPA partnerships
Collaboration between employers, brokers and third-party administrators will be essential to developing customized, cost-effective and employee-friendly solutions.
What Trump’s ‘Great Healthcare Plan’ means for drug costs and price transparency
The legislation calls on Congress to lower prescription drug costs, shift subsidies directly to consumers, and enforce strict price transparency.
Healthcare costs are forcing employers to reconsider their benefits strategy
Employers are under pressure to keep benefits competitive while controlling costs, driving new scrutiny of PBMs, hospital prices and GLP-1 coverage for 2027.
Benefits Think Success in self-insurance hinges on preparation
Setting clear expectations and equipping health plan members with usable information will build trust and eliminate employee friction in the face of change.
Louis C. Bernardi
BritePath